SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-24-138368
Filing Date
2024-05-14
Accepted
2024-05-14 17:06:37
Documents
1
Group Members
VERSANT SIDE FUND IV, L.P.VERSANT VENTURE CAPITAL IV, L.P.VERSANT VENTURE MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d814816dsc13da.htm SC 13D/A 80006
  Complete submission text file 0001193125-24-138368.txt   81848
Mailing Address ONE SANSOME STREET SUITE 1650 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET SUITE 1650 SAN FRANCISCO CA 94104 650-233-2211
Versant Ventures IV, LLC (Filed by) CIK: 0001456589 (see all company filings)

IRS No.: 263080143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Subject) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88266 | Film No.: 24945587
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)